NEW YORK, Sept. 15, 2014 /PRNewswire/ -- OTC Markets Group
Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected
financial marketplaces, today announced Antibe Therapeutics Inc.
(TSX-V: ATE; OTCQX: ATBPF), a human drug development company, has
qualified to trade on OTCQX®, the best marketplace.
Logo -
http://photos.prnewswire.com/prnh/20110118/MM31963LOGO
Antibe begins trading today on OTCQX under the symbol "ATBPF."
U.S. investors can find current financial disclosure and
Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"Antibe is developing improved versions of existing
non-steroidal anti-inflammatory drugs, NSAIDs, a $12 billion global market with a key unmet need,"
said R. Cromwell Coulson, President
and CEO of OTC Markets Group. "We are pleased to welcome
Antibe to our family of established, investor-focused companies on
OTCQX and wish the company continued growth and success."
Dr. Michael Bumby, Antibe's CFO
said, "We view trading on OTCQX as an important step in our capital
markets strategy as we continue to build our company and broaden
our development portfolio."
Merriman Capital, Inc. serves as Antibe's Principal American
Liaison ("PAL") on OTCQX, responsible for providing professional
guidance on OTCQX requirements.
About Antibe Therapeutics Inc.
Antibe develops safer
medicines for pain and inflammation. Antibe's technology
involves linking a hydrogen sulfide-releasing molecule to an
existing drug to produce a patented, improved medicine.
Antibe's ATB-346 targets the global need for a safer non-steroidal
anti-inflammatory drug (NSAID).
About OTC Markets Group Inc.
OTC Markets Group Inc.
(OTCQX: OTCM) operates Open, Transparent and Connected financial
marketplaces for 10,000 U.S. and global securities. Through
our OTC Link® ATS, we directly link a diverse network of
broker-dealers that provide liquidity and execution services for a
wide spectrum of securities. We organize these securities
into marketplaces to better inform investors of opportunities and
risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture
Marketplace; and OTC Pink®, The Open Marketplace. Our
data-driven platform enables investors to easily trade through the
broker of their choice at the best possible price and empowers a
broad range of companies to improve the quality and availability of
information for their investors. To learn more about how we
create better informed and more efficient financial marketplaces,
visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and
SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
SOURCE OTC Markets Group Inc.